Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies

Clinical trial NCT03414450 · WITHDRAWN

Trial details

NCT number: NCT03414450
Sponsor: EDDC (Experimental Drug Development Centre), A*STAR Research Entities
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)Ph- Acute Lymphoblastic Leukemia (Ph-ALL)Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+)Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+)

Start date: 2018-04-25
Primary completion: 2022-02-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.